Search research articles
Contact Us
Filters
Showing results (1-10 of 32) with videos related to
Page
of 4
Sort By:
Archives of Dermatology
|
June 29, 2000
Value of capillary microscopy in the diagnosis of hereditary hemorrhagic telangiectasia
J J Mager, C J Westermann
Rhinology
|
January 7, 2016
Follow-up of Thalidomide treatment in patients with Hereditary Haemorrhagic Telangiectasia
A Hosman, C J J Westermann, R Snijder, et al.
Chest
|
November 11, 2022
Evolution of Pulmonary Arteriovenous Malformations: The Role of Contrast Echocardiography
J Hessels, S Kroon, V V M Vorselaars, et al.
Angiogenesis
|
March 1, 2020
Intranasal Efudix reduces epistaxis in hereditary hemorrhagic telangiectasia
D V C de Jel, F J M Disch, S Kroon, et al.
International Journal of Cardiology. Heart & Vasculature
|
March 13, 2019
Long-term clinical value and outcome of riociguat in chronic thromboembolic pulmonary hypertension
M C J van Thor, L Ten Klooster, R J Snijder, et al.
Respiratory Medicine
|
May 19, 2020
Long-term real world clinical outcomes of macitentan therapy in chronic thromboembolic pulmonary hypertension
M C J van Thor, L Ten Klooster, R J Snijder, et al.
International Journal of Cardiology. Heart & Vasculature
|
June 11, 2020
Does combination therapy work in chronic thromboembolic pulmonary hypertension?
M C J van Thor, R J Snijder, J C Kelder, et al.
Journal of Neurosurgery
|
May 4, 2000
Bleeding risk of cerebrovascular malformations in hereditary hemorrhagic telangiectasia
R B Willemse, J J Mager, C J Westermann, et al.
Rhinology
|
April 23, 2009
The effect of N-acetylcysteine on epistaxis and quality of life in patients with HHT: a pilot study
E M de Gussem, R J Snijder, F J Disch, et al.
Lung
|
October 5, 2019
Bosentan or Macitentan Therapy in Chronic Thromboembolic Pulmonary Hypertension?
M C J van Thor, L Ten Klooster, R J Snijder, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 32) with videos related to
Sort By:
Page
of 4
Archives of Dermatology
|
June 29, 2000
Value of capillary microscopy in the diagnosis of hereditary hemorrhagic telangiectasia
J J Mager, C J Westermann
Rhinology
|
January 7, 2016
Follow-up of Thalidomide treatment in patients with Hereditary Haemorrhagic Telangiectasia
A Hosman, C J J Westermann, R Snijder, et al.
Chest
|
November 11, 2022
Evolution of Pulmonary Arteriovenous Malformations: The Role of Contrast Echocardiography
J Hessels, S Kroon, V V M Vorselaars, et al.
Angiogenesis
|
March 1, 2020
Intranasal Efudix reduces epistaxis in hereditary hemorrhagic telangiectasia
D V C de Jel, F J M Disch, S Kroon, et al.
International Journal of Cardiology. Heart & Vasculature
|
March 13, 2019
Long-term clinical value and outcome of riociguat in chronic thromboembolic pulmonary hypertension
M C J van Thor, L Ten Klooster, R J Snijder, et al.
Respiratory Medicine
|
May 19, 2020
Long-term real world clinical outcomes of macitentan therapy in chronic thromboembolic pulmonary hypertension
M C J van Thor, L Ten Klooster, R J Snijder, et al.
International Journal of Cardiology. Heart & Vasculature
|
June 11, 2020
Does combination therapy work in chronic thromboembolic pulmonary hypertension?
M C J van Thor, R J Snijder, J C Kelder, et al.
Journal of Neurosurgery
|
May 4, 2000
Bleeding risk of cerebrovascular malformations in hereditary hemorrhagic telangiectasia
R B Willemse, J J Mager, C J Westermann, et al.
Rhinology
|
April 23, 2009
The effect of N-acetylcysteine on epistaxis and quality of life in patients with HHT: a pilot study
E M de Gussem, R J Snijder, F J Disch, et al.
Lung
|
October 5, 2019
Bosentan or Macitentan Therapy in Chronic Thromboembolic Pulmonary Hypertension?
M C J van Thor, L Ten Klooster, R J Snijder, et al.
Page
of 4